As an international leader in the field of cardiac arrhythmia research, the lab’s efforts will undoubtedly lead to groundbreaking advances in cardiac care.
The mission of the Electrophysiology Clinical Research & Innovations department (ECRI) is to create and develop an infrastructure for translational and clinical cardiac arrhythmia research and innovation, and to be an internationally recognized leader in the field of cardiac arrhythmias research and management.
The team does this through a specific focus on translational research that will innovate devices and techniques used to detect, manage and treat various cardiac conditions, in particular arrhythmias. Led by Director Mehdi Razavi, MD, the team emphasizes the importance of innovations that will improve healthcare outcomes for hospitals as well as patient’s and their quality of life.
“Electrophysiology is evolving rapidly, with new technologies transforming how we treat complex arrhythmias. We’re at the forefront of advancing these innovations to improve patient outcomes.”
Developing New Pacemaker Technology
Texas Heart Institute’s Electrophysiology Clinical Research & Innovations team has been working over the last several years with partners at Rice University and University of California, Los Angeles (UCLA) to improve pacemaker technology – a commonly used, but relatively unchanged device that helps to control abnormal heart rhythms.
Innovating to Make ICDs Less Painful
The team in the Electrophysiology Clinical Research & Innovations & lab are developing small chips that could improve implantable cardioverter defibrillators (ICDs). ICDs, which are often used to prevent sudden cardiac death in patients with life-threatening arrhythmias, are a very effective technology, but they do have drawbacks.
Director, Electrophysiology Clinical Research & Innovations
Associate Director
Senior Research Engineer
Research Engineer II
Senior Research Scientist
Engineering Program Manager,
The Texas Heart Institute’s Electrophysiology Clinical Research & Innovations department (ECRI) is pioneering some of the most ground breaking cardiac arrhythmias research and management today in collaboration with institutions across the US. With a history of firsts in man devices, the next first in cardiac arrhythmia treatments is already happening at the Texas Heart Institute.
To facilitate the development and implementation of new therapeutic modalities and modification of current diagnostic and therapeutic approaches, close collaboration is maintained with a number of groups, including:
Electrophysiology Clinical Research and Innovations
MC 2-255
6770 Bertner Avenue
Houston, Texas 77030
Visit U.S. News & World Report
